![This shows the outline of a head](https://neurosciencenews.com/files/2023/02/ms-biomarker-neurosicences-public.jpg)
The blood level of the glial fibrillary acidic protein (GFAP) cellular component increases when astrocytes are damaged or activated. Elevated levels of GFAP in the blood can indicate both the current and future progression of multiple sclerosis.
from Neuroscience News https://ift.tt/Z0U6LrV
Comments
Post a Comment